| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.79B | -6.0% |
| Cost of Revenue | $2.68B | +1.1% |
| Gross Profit | $7.12B | -8.4% |
| R&D Expense | $1.33B | +0.4% |
| SG&A Expense | $963.0M | +4.6% |
| Operating Income | $2.35B | -19.6% |
| Interest Expense | $235.0M | -12.6% |
| Pre-tax Income | -$1.60B | -502.3% |
| Income Tax | -$327.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.15B | +56.2% |
| Accounts Receivable | $90.0M | -8.2% |
| Current Assets | $9.29B | +2.0% |
| Total Assets | $20.85B | -21.7% |
| Current Liabilities | $4.27B | -7.6% |
| Long-term Debt | $7.72B | -0.1% |
| Total Liabilities | $15.70B | -6.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.25B | -15.2% |
| Capital Expenditures | $449.0M | +1.1% |
| Investing Cash Flow | $2.46B | -32.8% |
| Financing Cash Flow | -$3.79B | +41.9% |
| Free Cash Flow | $1.80B | -18.4% |
| -324.0% |
| Net Income | -$1.27B | -109.3% |
| EPS (Basic) | -$2.27 | -110.9% |
| EPS (Diluted) | -$2.27 | -111.1% |
| Stockholders' Equity |
| $5.15B |
| -47.3% |